Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PLUS THERAPEUTICS, INC. Director's Dealing 2012

Dec 21, 2012

34301_dirs_2012-12-21_b65c907d-cf4e-465d-b0e6-133c73a54f47.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2012-12-19

Reporting Person: Dean Lloyd H (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-12-19 Common Stock P 25000 $2.85 Acquired 40000 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 21000 Direct
Restricted Stock 10000 Direct

Footnotes

F1: Mr. Dean purchased the shares in connection with a public offering of company shares which closed December 19, 2012.

F2: These shares are owned by Lloyd H. Dean,TTE and Suzanne R. Dean, TTE, U/A DTD 8/13/2002, the Dean Family Trust.